Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.96 USD | -3.69% | -9.10% | -36.52% |
04-09 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
04-09 | Syros Gets Fast Track Label For Tamibarotene to Treat Acute Myeloid Leukemia; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.52% | 138M | |
+22.23% | 46.4B | |
-1.69% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+9.85% | 26.01B | |
-19.72% | 19.52B | |
+29.90% | 12.43B | |
-0.24% | 12.18B | |
-0.77% | 12.13B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals Completes Enrollment of 190 People in Phase 3 Trial of Tamibarotene